openPR Logo
Press release

Pulmonary Arterial Hypertension Market: Profound Growth at 9.1% CAGR, Key Trends, and Drivers Forecast

Pulmonary Arterial Hypertension Market Growth

Pulmonary Arterial Hypertension Market Growth

"Remarkable developments in pulmonary arterial hypertension treatments are driving the market forward, projecting strong growth in the coming years.

What Is The Projected Market Size Of The Global Pulmonary Arterial Hypertension Market And Its Growth Rate?
From 2024 to 2025, the increase in the pulmonary arterial hypertension market size is expected to trend from $8.47 billion to $9.24 billion. This growth is projected to occur at a compelling compound annual growth rate (CAGR) of 9.1%. Key factors driving growth in this historic period include:

- Increased awareness and diagnosis of pulmonary arterial hypertension (PAH)
- Increased healthcare expenditure
- Growth in aging population
- Expansion of pulmonary arterial hypertension treatment options
- Rise in research and development activities in pulmonary hypertension

The pulmonary arterial hypertension market size is further expected to accelerate to $12.97 billion in 2029, occurring at a CAGR of 8.8%. Growth in this forecast period is set to be attributed to:

- Adoption of novel therapies for pulmonary arterial hypertension
- Increased focus on early detection and diagnosis
- Growing pipeline of PAH drugs and therapies
- Integration of precision medicine in PAH treatment
- Expansion of healthcare infrastructure in emerging markets

What Is Driving The Growth In The Pulmonary Arterial Hypertension Market?
The remarkable upturn in the prevalence of pulmonary arterial hypertension (PAH) disease is a significant driver for the pulmonary arterial hypertension market growth. The rising number of PAH patients necessitating hospitalization and medical care for treatment is expected to catapult the demand for relevant medications in the imminent years. A study published by the National Organization for Rare Disorders, Inc., estimates that each year, the USA sees 500-1000 new cases of PAH, equivalent to one to two individuals per million. Europe presumably depicts similar incidence rates.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5954&type=smp

Who Are the Key Players Driving Pulmonary Arterial Hypertension Market Growth?
Significant players operating in the pulmonary arterial hypertension market comprise:

- United Therapeutics Corporation
- Acceleron Pharma Inc.
- Actelion Pharmaceuticals US Inc.
- Bayer AG
- Eli Lilly and Company
- Gilead Sciences Inc.
- GlaxoSmithKline plc
- Johnson & Johnson
- Liquidia Technologies Inc.
- Lupin Pharmaceuticals Inc.
- Natco Pharma Ltd.
- Pfizer Inc.
- Sandoz AG
- Teva Pharmaceutical Industries Ltd.
- Zydus Pharmaceutical USA Inc.
- Allegheny Health Network
- Cedars-Sinai Medical Center
- Cleveland Clinic
- Houston Methodist Hospital
- Johns Hopkins Medicine
- Massachusetts General Hospital
- Mayo Clinic
- MedStar Heart & Vascular Institute
- National Jewish Health
- NewYork-Presbyterian Hospital
- Ochsner Medical Center
- Royal Brompton & Harefield NHS Foundation Trust
- Rush University Medical Center
- Stanford Health Care
- Swedish Medical Center
- Temple University Hospital
- University of California Health

What Are The Key Trends In The Pulmonary Arterial Hypertension Market?
The imminent forecast period indicates several growing trends in the pulmonary arterial hypertension market. These trends encompass advancements in medical imaging and diagnostic technologies, collaboration and partnerships for drug development, patient-centric approaches in pulmonary arterial hypertension management, and the increased use of combination therapy.

What Are The Segments Of The Global Pulmonary Arterial Hypertension Market?
The pulmonary arterial hypertension market is segmented as follows:

- By Drug Class: Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators
- By Route Of Administration: Oral, Intravenous Or subcutaneous, Inhalational
- By Distribution Channel: Retail, Online

Which Region Leads The Pulmonary Arterial Hypertension Market?
North America spearheaded the pulmonary arterial hypertension market in 2024 and covers various spaces including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pulmonary-arterial-hypertension-global-market-report

What Is Covered In The Pulmonary Arterial Hypertension Market Global Market Report?
- Market Size Analysis: Analyze the Pulmonary Arterial Hypertension Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Pulmonary Arterial Hypertension Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Pulmonary Arterial Hypertension Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Pulmonary Arterial Hypertension Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/Customise?id=5954&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company:
With more than 15,000 reports spanning 27 industries and over 60 geographies, The Business Research Company is renowned for providing comprehensive data-rich research and valuable insights. Equipped with over 1,500,000 datasets, groundbreaking secondary research, and invaluable perspectives from industry leaders, you gain necessary insights to stay ahead in your industry. Our premier product, the Global Market Model , is a pioneering market intelligence platform providing rigorous forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Arterial Hypertension Market: Profound Growth at 9.1% CAGR, Key Trends, and Drivers Forecast here

News-ID: 3826656 • Views:

More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Pulmonary

Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028. The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments